Powder: -20°C for 3 years | In solvent: -80°C for 1 year
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 550.00 | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 570.00 |
Description | 7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression. |
Source |
Molecular Weight | 486.693 |
Formula | C30H46O5 |
CAS No. | 150972-72-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
7,8-Didehydrocimigenol 150972-72-8 Apoptosis Cytoskeletal Signaling DNA Damage/DNA Repair MAPK Metabolism NF-Κb PI3K/Akt/mTOR signaling ERK TNF IκB/IKK Akt NF-κB PPAR 7,8 Didehydrocimigenol 7,8Didehydrocimigenol inhibitor inhibit